Oneness Biotech Co., Ltd.

Media Coverage

Media Coverage	Date	Title
BioSpace	23 Jul. 2024	Oneness Fespixon^® has been out-licensed to CR Double- Crane for exclusive commercialization in China, a significant step forward of the blockbuster new drug’s global launch
The Star	8 Jul. 2023	Health Ministry approves the first natural products with therapeutic claims, says Health DG
INF News	29 Sep. 2022	The first in the world!New drug for diabetic foot ulcer: research and development code "ON101"
DIABETES IN CONTROL	16 Jul. 2022	Diabetes: Better Relief for Ulcerated Feet On the Horizon
Medivizor	9 Oct. 2021	How effective is a new macrophage-regulating drug for wound healing in patients with diabetic foot ulcers?
Diabetes Self-management	7 Oct. 2021	New Topical Drug Helps Foot Ulcers Heal in Clinical Trial
Medscape	10 Sep. 2021	Novel Diabetic Foot Ulcer Cream Shows Promise in Phase 3 Trial
Medical Dialogues	10 Sep. 2021	Topical Application Of Novel Drug Improved Healing In Patients With Diabetic Fool Ulcers: JAMA
2 minute medicine	8 Sep. 2021	Novel macrophage-regulating cream demonstrated superior therapeutic efficacy for the treatment of diabetic foot ulcers compared to standard absorbent dressing
BioSpace	7 Sep. 2021	A novel macrophage-regulating new drug has shown promise in treating diabetic foot ulcers according to the latest issue of article published by the JAMA Network Open
Podiatry Management	7 Sep. 2021	RE: Novel Macrophage-Regulating Drug-Effect on Wound Healing in Patients With DFUs
Medpage Today	3 Sep. 2021	Topical Cream Effective Against Diabetic Foot Ulcers — Investigational compound regulates macrophages, is "active-healing alternative," researchers

↑

關閉

建議您使用以下瀏覽器觀看合一網站，
以獲得最佳瀏覽效果。

要下載瀏覽器，請直接點擊以下:

IE瀏覽器現已不支援大多數網站，並將於2022年6月終止服務

如何使用IE找到Microsoft Edge?

開啟新分頁(紅色框)
於搜尋框中打入Edge(紅色框)，並按搜尋(藍色框)
點擊【立即啟動】(藍框處)打開 Microsoft Edge